For patients with severe COVID-19, cholangiopathy was a late complication with potential for progressive biliary injury or liver failure, according to a study published in
The FDA issued a complete response letter to Incyte indicating it cannot approve the company’s biologics license application that seeks approval of retifanlimab for certain
Bristol Myers Squibb in consultation with the FDA voluntarily withdrew the indication for nivolumab as monotherapy for patients with hepatocellular carcinoma previously treated with sorafenib.The
Healio Gastroenterology presents the following reports on recent news in COVID-19.These stories include research on liver transplantation, hepatitis B, GI symptoms that persist in patients
The Florida Gastroenterologic Society was originally conceived in 1965 by James L. Borland, M.D., a well respected Gastroenterologist who practiced in Jacksonville, Florida.